Loading provider…
Loading provider…
Hematology & Oncology Physician in Leawood, KS
NPI: 1750355871Primary Practice Location
MENORAH MEDICAL CENTER
5721 W 119th St, Overland Park, KS
Primary Employer
Midwest Oncology Associates LLC
HCAHealthcare.com
HQ Phone
Get MD Joseph's Phone Numberphone_androidMobile
Get MD Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
KS State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 319 | 502 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 309 | 712 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 108 | 347 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 101 | 119 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 60 | 60 |
Authors: John Hainsworth, David Waterhouse, Howard Burris, Tarek Mekhail, Robert Whorf, Michael Mccleod, Ray Page, Dianna Shipley, David Spigel
Journal: Oncologist
Publication Date: 2019-08-16
Authors: Tracey Weisberg, Thomas Frazier, Wendy Bravo, Kevin Fox, Christine Teal, Devchand Paul, Christine Laronga, Michael Broder, Anita Mcswain
Journal: Pharmaceuticals (Basel)
Publication Date: 2015-03-17
Lead Sponsor: GlaxoSmithKline
Collaborators: iTeos Belgium SA
Intervention / Treatment: DRUG: Docetaxel, DRUG: Ipilimumab, DRUG: Dostarlimab, DRUG: GSK6097608, DRUG: Feladilimab, DRUG: GSK4428859A
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Pembrolizumab, DRUG: M7824
Lead Sponsor: G1 Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Trilaciclib